Dataset Information

Dual-layer spectral computed tomography aortography using a seventy-five-percent-reduced iodine dose protocol and multiparameter spectral imaging: comparison with conventional computed tomography imaging.

ABSTRACT:

Background

Computed tomography angiography (CTA) is the recommended diagnostic and follow-up imaging modality for acute aortic dissection (AD). However, the high-contrast medium burden associated with repeated CT aortography follow-ups remains a significant concern. This prospective study aimed to assess whether an ultra-low contrast dose (75% cutoff) aortic CTA protocol on dual-layer spectral CT could achieve comparable image quality with the full dose protocol. We also investigated the image quality of the virtual noncontrast (VNC) images derived from the ultra-low dose protocol.

Methods

This study included 37 consecutive patients who were referred to aortic CTA from May 2022 to August 2022. The enrolled patients underwent full-dose contrast CTA and ultra-low dose (reduced to 25% of conventional) contrast CTA on dual-layer spectral CT in 1 day. Virtual monochromatic images (VMIs) were reconstructed with 40 and 70 keV. The VNC images were reconstructed for both protocols. Objective image quality evaluation, recorded as signal-to-noise ratios (SNRs) and contrast-to-noise ratios (CNRs), was compared between the groups using 1-way analysis of variance and post hoc analysis with Bonferroni correction. Subjective image quality was also compared between the groups. Finally, VNC images derived from the low-dose (VNC_low) and full-dose (VNC_full) protocols were compared to the true noncontrast (TNC) images.

Results

Neither CNR nor SNR was lower for the 40-keV images reconstructed from the ultra-low dose group compared to the conventional images. Both were significantly higher than those of the 70-keV images. Regarding subjective image quality, vessel enhancement was not significantly different between the 40-keV VMI and full-dose images [ascending aorta (AAO): 4.37±0.46 vs. 4.57±0.48, P=0.096; brachiocephalic arteries: 4.34±0.45 vs. 4.51±0.49, P=0.152; abdominal aortic side branch: 4.42±0.48 vs. 4.51±0.49, P=0.480]. The VNC_low images were similar to the TNC images but significantly different from the VNC_full images (P<0.001).

Conclusions

Ultra-low contrast aortic CTA with a 75%-reduced iodine dose using dual-layer spectral CT and the derived VNC achieved image quality comparable to that of conventional CTA and TNC images.

SUBMITTER: Wang A

PROVIDER: S-EPMC10585532 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Dual-layer spectral computed tomography aortography using a seventy-five-percent-reduced iodine dose protocol and multiparameter spectral imaging: comparison with conventional computed tomography imaging.

Wang Aijie A Li Wanjiang W Huang Wenyu W Luo Mao M Xiao Wendan W Qin Chaoyi C Dong Shushan S Liu Haiwei H Li Zhenlin Z Diao Kaiyue K

Quantitative imaging in medicine and surgery 20230918 10

<h4>Background</h4>Computed tomography angiography (CTA) is the recommended diagnostic and follow-up imaging modality for acute aortic dissection (AD). However, the high-contrast medium burden associated with repeated CT aortography follow-ups remains a significant concern. This prospective study aimed to assess whether an ultra-low contrast dose (75% cutoff) aortic CTA protocol on dual-layer spectral CT could achieve comparable image quality with the full dose protocol. We also investigated the ...[more]

PMID: 37869326

Similar Datasets

Project description:BackgroundLung adenocarcinoma (LUAD) is the leading cause of cancer-related deaths. High-resolution computed tomography (HRCT) has improved the detection of ground glass nodules (GGNs), which are early indicators of lung cancer. Accurate assessment of GGN invasiveness is crucial for determining the appropriate surgical approach. Dual-layer spectral detector computed tomography (DLCT) offers advanced imaging capabilities, including electron density and iodine density, which enhance the evaluation of GGN invasiveness. This study aims to develop a machine learning (ML) model that integrates DLCT parameters and clinical features to predict the invasiveness of GGNs in LUAD, aiding in surgical decision-making and prognosis improvement.MethodsThe retrospective study encompassed 272 patients who were diagnosed with LUAD, comprising 154 cases of invasive adenocarcinomas (IA) and 118 cases of pre-invasive minimally invasive adenocarcinoma (MIA) which were then randomly allocated into a training set and a test set. Six ML models were developed based on five DLCT parameters (conventional, iodine density, virtual noncontrast, electron density, and effective atomic number). Subsequently, a nomogram was constructed using multi-factor logistic regression, incorporating radiomic characteristics and clinicopathological risk factors.ResultsThe ML model based on conventional plus electron density performed better than the models with other DLCT parameters, with the area under the curves (AUCs) of 0.945 and 0.964 in the training and test sets, respectively. The clinical model and radiomics score (Rad-score) were combined in the logistic regression to construct a joint model, of which the AUCs were 0.974 in the training sets and 0.949 in the test sets. The ML model effectively differentiated between IA and pre-invasive MIA, and further classified patients into high and medium risk categories for invasion using waterfall plots.ConclusionsThe ML model based on DLCT parameters helps predict the invasiveness of GGNs and classifies the GGNs into different risk grades.

Project description:BackgroundEarly rectal neoplasms can be treated endoscopically with good prognosis, yet usually present with unspecific or an absence of signs and symptoms and are detected largely by invasive endoscopy with less compliance to screening. The purpose of this cross-sectional study was to explore the diagnostic value of dual-layer spectral detector computed tomography (DSCT) imaging for early rectal neoplasm.MethodsPatients who underwent DSCT for evaluation of rectal lesion or routine examination between September 2022 to September 2023 at West China Hospital were prospectively included and identified as group A (control, n=76), group B (rectal advanced adenomas and ≤T1 rectal cancer, n=59), and group C (≥T2 staging rectal cancer, n=74). Lesion visualization was graded to assess image quality. Spectral quantitative measurement, such as Hounsfield unit (HU)40 keV, HU70 keV, iodine concentration (IC), effective atomic number (Zeff), and the slope of spectral curve (λ), was analyzed and compared. Receiver operating characteristic (ROC) curves were generated to evaluate the diagnostic efficacy of spectral parameters. A comparison of ROC curves was applied to test the significance of differences between the area under the curves (AUCs).ResultsCompared to poly-energetic images (PEIs), the multiple parameters from DSCT were of greater capability to recognize rectal lesions. There were significant differences in HU40 keV (208.01±43.60 vs. 255.53±45.16), HU70 keV (87.06±18.55 vs. 100.78±18.26), IC [1.91 (1.71, 2.28) vs. 2.58±0.49], Zeff [8.33 (8.25, 8.50) vs. 8.61±0.20], and λ [3.80 (3.41, 4.52) vs. 5.16±1.00] between the early neoplastic lesions in rectum and the advanced rectal cancer (P<0.001). Significant correlations were found between the DSCT parameters and tumor staging (P<0.001). Furthermore, the AUCs of IC, Zeff, λ, and HUPEI were all above 0.90 for early rectal neoplasm detection, with additional capability of discriminating early rectal neoplasm from advanced rectal cancer.ConclusionsDSCT improved tumor conspicuity and the detection of the early rectal neoplastic lesion, suggesting that it is a promising screening tool in clinical practice.

Project description:BackgroundVirtual noncontrast (VNC) images generated by dual-layer spectral computed tomography (DLCT) remove iodine influence from enhanced images to simulate true noncontrast (TNC) images. Previous research has demonstrated the high comparability of abdominal VNC images with TNC images, suggesting their potential as substitutes. Given the thyroid's significant iodine content, this study evaluated the efficacy of VNC images for removing both intrinsic and extrinsic iodine through an analysis of computed tomography (CT) attenuation and iodine density in TNC and enhanced VNC thyroid images.MethodsA total of 115 thyroid nodules were classified into papillary thyroid carcinoma (PTC) and nodular goiter (NG) groups based on pathology. Patients underwent both noncontrast and enhanced neck scans, with attenuation values of CT and iodine density measured for nodules, normal thyroid, and the carotid artery on conventional and VNC images. The study calculated CT attenuation and iodine density for both intrinsic and external iodine content. The Wilcoxon rank-sum test was used to compare intrinsic and external iodine differences between the PTC and NG groups. The Spearman test was used for correlation assessment within each group, and Bland-Altman analysis was conducted to evaluate CT attenuation consistency between VNC images from nonenhanced scans (VNCn) and VNC images from enhanced scans (VNCe) within the groups.ResultsThe CT attenuation values of intrinsic iodine showed no differences between nodules, normal thyroid, and carotid artery in the PTC and NG groups (P>0.05). However, there was a difference in the CT attenuation values of external iodine for nodules between the two groups (P<0.05), while no difference was found for normal thyroid or the carotid artery between the groups (P>0.05). The correlation between CT attenuation values of the nodules, normal thyroid, and carotid artery for intrinsic iodine and iodine density was high in both the PTC group (r=0.919, r=0.951, r=0.592, respectively; P<0.001) and the NG group (r=0.925, r=0.973, r=0.721, respectively; P<0.001). Similarly, there was a strong correlation between the CT attenuation values of the nodules, normal thyroid, and carotid artery for extrinsic iodine and iodine density in the PTC group (r=0.960, r=0.965, r=0.904, respectively; P<0.001) and the NG group (r=0.979, r=0.967, r=0.963, respectively; P<0.001). There was no statistically significant difference in the CT attenuation values of the normal thyroid in VNCn and VNCe images (P>0.05), while the CT attenuation values of nodules and the carotid artery in VNCn and VNCe images in the two groups were significantly different (P<0.05). Bland-Altman scatter plots showed that, apart from the normal thyroid in the NG group, the consistency of CT attenuation values on VNCn and VNCe images was generally poor (more than 5% of data points outside the consistency limit).ConclusionsVNC images show certain ability to remove intrinsic and external iodine from the thyroid. In the diagnosis of thyroid nodules, enhanced VNC images of the thyroid cannot replace conventional nonenhanced images.

Project description:BackgroundThis study had two aims: (a) to evaluate the utility of fluorine 18-fluorodeoxyglucose (FDG) positron emission tomography (PET)-computed tomography (CT) in detecting occult disease recurrence with raised carcinoembryonic antigen (CEA) and (b) to establish the prognostic effects of early detection of disease recurrence in patients with colorectal cancer (CRC).Patients and methodsClinico-pathological data were obtained from all consecutive patients undergoing CRC surveillance from 2004 to 2010 who had an elevated CEA level (>3 ng/mL in nonsmokers, >5 ng/mL in smokers) but normal or equivocal conventional investigations. Histopathological confirmation or a minimum of 12 months' clinical and radiological follow-up were required to ascertain disease relapse.ResultsA total of 1,200 patients were screened; of those, 88 (59% men; mean age, 66 years [SD, 9.6]) eligible patients (67 with normal and 21 with equivocal results on conventional investigations) were identified. Recurrent disease was detected in 56 of 88 patients (64%). The sensitivity of FDG PET-CT to detect recurrence was 49 of 56 (88%; 95% confidence interval [CI], 76%-95%) and specificity was 28 of 32 (88%; 95% CI, 71%-97%). Twenty-seven of 49 (55%) patients with PET-CT-detected relapsed disease were deemed eligible for further curative therapy; 19 (70%) went on to receive potentially curative therapy. The median time to progression (8.8 months [interquartile range (IQR), 4.5-19.1 months] vs. 2.2 months [IQR, 0.7-5.6]), median overall survival (39.9 months [IQR, 23.6-65.4 months] vs. 15.6 months [IQR, 7.3-25.7 months]), and 5-year survival (36.8% [95% CI, 16.5%-57.5%] vs. 6.1% [95% CI, 1.1%-17.6%]; p ≤ .001) were higher in patients who received potentially curative therapy than in those who received noncurative therapy.ConclusionFDG PET-CT is a highly sensitive and specific tool for the detection of occult CRC recurrence. In >50% of patients, recurrent disease may still be potentially amenable to curative therapy. Long-term survival can be achieved in such patients.Implications for practiceColorectal cancer (CRC) patients who, on follow-up, have normal or equivocal results on clinical investigations but raised carcinoembryonic antigen (CEA) levels pose a significant challenge to treating physicians. This study supported the notion that the early use of fluorodeoxyglucose (FDG) positron emission tomography (PET)-computed tomography (CT) may have predictive and prognostic value in management of such patients. Long-term disease control and cure can be achieved in a subgroup of this patient population with low-volume disease relapse who are amenable to potentially curative treatment strategies. Reassuringly, the sensitivity and specificity for recurrence did not significantly vary as a function of the CEA level, suggesting that even with a minimal CEA rise, benefit can be attained by conducting FDG PET-CT in a timely manner.

Dataset Information

Dual-layer spectral computed tomography aortography using a seventy-five-percent-reduced iodine dose protocol and multiparameter spectral imaging: comparison with conventional computed tomography imaging.

Background

Methods

Results

Conclusions

Publications

Dual-layer spectral computed tomography aortography using a seventy-five-percent-reduced iodine dose protocol and multiparameter spectral imaging: comparison with conventional computed tomography imaging.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets